IGFBP7 and acute kidney injury: In 2016, we introduced [TIMP-2]∙[IGFBP7] into our routine clinical practice; in this observational cohort study we investigated the utility of [TIMP-2]∙[IGFBP7] measurement at ICU admission for the early identification of patients at risk of AKI.